DLB Stock Recent News

This monthly article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.

Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely.

Dolby Laboratories (DLB) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

The headline numbers for Dolby Laboratories (DLB) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

DLB's fiscal first-quarter 2025 performance gains from steady growth in the Licensing, and the Products and services segments.

– Study demonstrated strong therapeutic responses across behavioral, functional, cognitive, and movement measures in patients with mild-to-moderate DLB –

Dolby Laboratories, Inc. (NYSE:DLB ) Q1 2025 Earnings Conference Call January 29, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - President, CEO & Director Robert Park - SVP & CFO Conference Call Participants Steven Frankel - Rosenblatt Securities Patrick Sholl - Barrington Research Ralph Schackart - William Blair Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing First Quarter Fiscal Year 2025 results.

Dolby Laboratories (DLB) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.01 per share a year ago.

SAN FRANCISCO , Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. "We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories.

DLB's fiscal first-quarter performance is likely to have gained from momentum across Dolby Atmos and Dolby Vision amid soft device sales.